Thyroid disruption by perfluorooctane sulfonate (PFOS) and perfluorooctanoate (PFOA)

Journal of Endocrinological Investigation

Volumn 40, Issue 2, 2017, Pages 105-121

  Coperchini, F ^a   Awwad, O ^b   Rotondi, M ^a   Santini, F ^c   Imbriani, M ^a   Chiovato, L ^a  

^a UNIVERSITY OF PAVIA   (Italy)

^b UNIVERSITY OF JORDAN   (Jordan)

^c UNIVERSITY HOSPITAL OF PISA   (Italy)

Author keywords

PFOA; PFOS; Thyroid

Indexed keywords

ENDOCRINE DISRUPTOR; PERFLUOROOCTANESULFONIC ACID; PERFLUOROOCTANOIC ACID; THYROID HORMONE; ALKANESULFONIC ACID; FLUOROCARBON; OCTANOIC ACID DERIVATIVE;

CHEMISTRY; ENVIRONMENTAL EXPOSURE; HUMAN; IN VITRO STUDY; METABOLIC CLEARANCE RATE; NONHUMAN; OCCUPATIONAL EXPOSURE; POLLUTION; PREGNANCY; PRENATAL EXPOSURE; REVIEW; SYNTHESIS; THYROID CANCER; THYROID FUNCTION; THYROID GLAND; FEMALE; METABOLISM; THYROID DISEASES;

ALKANESULFONIC ACIDS; CAPRYLATES; FEMALE; FLUOROCARBONS; HUMANS; PREGNANCY; THYROID DISEASES;

EID: 85010902340     PISSN: 03914097     EISSN: 17208386     Source Type: Journal    
DOI: 10.1007/s40618-016-0572-z     Document Type: Review

References (87)

1. Papa V, Bimonte VM, Wannenes F, D’Abusco AS, Fittipaldi S, Scandurra R, Politi L, Crescioli C, Lenzi A, Di Luigi L, Migliaccio S (2015) The endocrine disruptor cadmium alters human osteoblast-like Saos-2 cells homeostasis in vitro by alteration of Wnt/β-catenin pathway and activation of caspases. J Endocrinol Invest 38:1345–1356
2. 1 offspring. J Endocrinol Invest. doi:10.1007/s40618-016-0539-0
3. Paoli D, Giannandrea F, Gallo M, Turci R, Cattaruzza MS, Lombardo F, Lenzi A, Gandini L (2015) Exposure to polychlorinated biphenyls and hexachlorobenzene, semen quality and testicular cancer risk. J Endocrinol Invest 38:745–752
4. Valentino R, D’Esposito V, Ariemma F, Cimmino I, Beguinot F, Formisano P (2016) Bisphenol A environmental exposure and the detrimental effects on human metabolic health: is it necessary to revise the risk assessment in vulnerable population? J Endocrinol Invest 39:259–263
5. Diamanti-Kandarakis E, Bourguignon JP, Giudice LC, Hauser R, Prins GS, Soto AM, Zoeller RT, Gore AC (2009) Endocrine-disrupting chemicals: an endocrine society scientific statement. Endocr Rev 30:293–342
6. Zareitalabad P, Siemens J, Hamer M, Amelung W (2013) Perfluorooctanoic acid (PFOA) and perfluorooctanesulfonic acid (PFOS) in surface waters, sediments, soils and wastewater—a review on concentrations and distribution coefficients. Chemosphere 91:725–732
7. Renner R (2001) Growing concern over perfluorinated chemicals. Environ Sci Technol 35:154A–160A
8. Trier X, Granby K, Christensen JH (2011) Polyfluorinated surfactants (PFS) in paper and board coatings for food packaging. Environ Sci Pollut Res Int 18:1108–1120
9. European Food Safety Authority (EFSA) (2008) Opinion of the scientific panel on contaminants in the food chain on perfluorooctane sulfonate (PFOS), perfluorooctanoic acid (PFOA) and their salts. EFSA J 653:1–131
10. Johnson JD, Gibson SJ, Ober RE (1984) Cholestyramine-enhanced fecal elimination of carbon-14 in rats after administration of ammonium [14C] perfluorooctanoate or potassium [14C] perfluorooctanesulfonate. Fundam Appl Toxicol 4:972–976
11. Kallenborn R, Berger U, Järnberg U (2004) Perfluorinated alkylated substances (PFAS) in the nordic environment. Nordic Council of Ministers, Tema Nord, Zavodskaya, p 552
12. Secretariat of the Stockholm Convention: The new POPs under the Stockholm Convention (2011) http://chm.pops.int/Implementation/NewPOPs/ThenewPOPs/tabid/672/Default.aspx
13. U.S. EPA. (Unites States Environmental Protection Agency) (2006) The 2010/2015 PFOA Stewardship Program. http://www.epa.gov/oppt/pfoa/pubs/stewardship/index.html
14. Giesy JP, Kannan K (2001) Global distribution of perfluorooctane sulfonate in wildlife. Environ Sci Technol 1(35):1339–1342
15. 3M (2000) Sulfonated perfluorochemicals in the environment: sources, dispersion, fate and effects (AR226-0545). 3M Company, St. Paul, MN
16. Valsecchi S, Rusconi M, Mazzoni M, Viviano G, Pagnotta R, Zaghi C, Serrini G, Polesello S (2015) Occurrence and sources of perfluoroalkyl acids in Italian river basins. Chemosphere 129:126–134
17. Boulanger B, Peck AM, Schnoor JL, Hornbuckle KC (2055) Mass budget of perfluorooctane surfactants in Lake Ontario. Environ Sci Technol 39:74–79
18. Pistocchi A, Loos R (2009) A map of European emissions and concentrations of PFOS and PFOA. Environ Sci Technol 43:9237–9244
19. Loos R, Wollgast J, Huber T, Hanke G (2007) Polar herbicides, pharmaceuticals, perfluorooctansulfonate (PFOS), perfluorooctanoate (PFOA), nonylphenol and its carboxylates and ethoxylates in surface and tap waters around Lake Maggiore in Northern Italy. Anal Bioanal Chem 387:1469–1478
20. Hundley SG, Sarrif AM, Kennedy GL (2006) Absorption, distribution, and excretion of ammonium perfluorooctanoate (APFO) after oral administration to various species. Drug Chem Toxicol 29:137–145
21. Jones PD, Hu W, De Coen W, Newsted JL, Giesy JP (2003) Binding of perfluorinated fatty acids to serum proteins. Environ Toxicol Chem 22:2639–2649
22. Olsen GW, Burris JM, Ehresman DJ, Froehlich JW, Seacat AM, Butenhoff JL, Zobel LR (2007) Half-life of serum elimination of perfluorooctanesulfonate, perfluorohexanesulfonate, and perfluorooctanoate in retired fluorochemical production workers. Environ Health Perspect 115:1298–1305
23. Elcombe CR, Elcombe BM, Foster JR, Chang SC, Ehresman DJ, Butenhoff J (2012) Hepatocellular hypertrophy and cell proliferation in Sprague–Dawleyrats from dietary exposure to potassium perfluorooctanesulfonate results from increased expression of xenosensor nuclear receptors PPARalpha and CAR/PXR. Toxicology 293:16–29
24. Bjork JA, Butenhoff JL, Wallace KB (2011) Multiplicity of nuclear receptor activation by PFOA and PFOS in primary human and rodent hepatocytes. Toxicology 288:8–17
25. Dong H, Curran I, Williams A, Bondy G, Yauk CL, Wade MG (2016) Hepatic miRNA profiles and thyroid hormone homeostasis in rats exposed to dietary potassium perfluorooctanesulfonate (PFOS). Environ Toxicol Pharmacol 41:201–210
26. Biegel LB, Hurtt ME, Frame SR, O’Connor JC, Cook JC (2001) Mechanisms of extrahepatic tumor induction by peroxisome proliferators in male CD rats. Toxicol Sci 60:44–55
27. Butenhoff JL, Kennedy GL Jr, Chang SC, Olsen GW (2012) Chronic dietary toxicity and carcinogenicity study with ammonium perfluorooctanoate in Sprague–Dawley rats. Toxicology 298:1–13
28. Chang ET, Adami HO, Boffetta P, Cole P, Starr TB, Mandel JS (2014) A critical review of perfluorooctanoate and perfluorooctanesulfonate exposure and cancer risk in humans. Crit Rev Toxicol 1:1–81
29. Lundin JI, Alexander BH, Olsen GW, Church TR (2009) Ammonium perfluorooctanoate production and occupational mortality. Epidemiology 20:921–928
30. Leonard RC, Kreckmann KH, Sakr CJ, Symons JM (2008) Retrospective cohort mortality study of workers in a polymer production plant including a reference population of regional workers. Ann Epidemiol 18:15–22
31. Steenland K, Woskie S (2012) Cohort mortality study of workers exposed to perfluorooctanoic acid. Am J Epidemiol 176:909–917
32. Vieira VM, Hoffman K, Shin HM, Weinberg JM, Webster TF, Fletcher T (2013) Perfluorooctanoic acid exposure and cancer outcomes in a contaminated community: a geographic analysis. Environ Health Perspect 121:318–323
33. Barry V, Winquist A, Steenland K (2013) Perfluorooctanoic acid (PFOA) exposures and incident cancers among adults living near a chemical plant. Environ Health Perspect 121:1313–1318
34. Frisbee SJ, Brooks AP Jr, Maher A, Flensborg P, Arnold S, Fletcher T, Steenland K, Shankar A, Knox SS, Pollard C, Halverson JA, Vieira VM, Jin C, Leyden KM, Ducatman AM (2009) The C8 health project: design, methods, and participants. Environ Health Perspect 117:1873–1882
35. Alexander BH, Olsen GW (2007) Bladder cancer in perfluorooctanesulfonyl fluoride manufacturing workers. Ann Epidemiol 17:471–478
36. Alexander BH, Olsen GW, Burris JM, Mandel JH, Mandel JS (2003) Mortality of employees of a perfluorooctanesulphonyl fluoride manufacturing facility. Occup Environ Med 60:722–729
37. Grice MM, Alexander BH, Hoffbeck R, Kampa DM (2007) Self-reported medical conditions in perfluorooctanesulfonyl fluoride manufacturing workers. J Occup Environ Med 49:722–729
38. Olsen GW, Burlew MM, Marshall JC, Burris JM, Mandel JH (2004) Analysis of episodes of care in a perfluorooctanesulfonyl fluoride production facility. J Occup Environ Med 46:837–846
39. Maestri L, Negri S, Ferrari M, Ghittori S, Fabris F, Danesino P, Rapid Imbriani M (2006) Determination of perfluorooctanoic acid and perfluorooctanesulfonate in human tissues by liquid chromatography/single quadrupole mass spectrometry. Commun Mass Spectrom 20:2728–2734
40. Coperchini F, Pignatti P, Lacerenza S et al (2015) Exposure to perfluorinated compounds: in vitro study on thyroid cells. Environ Sci Pollut Res Int 22:2287–2294
41. Song M, Kim YJ, Park YK, Ryu JC (2012) Changes in thyroid peroxidase activity in response to various chemicals. J Environ Monit 14:2121–2126
42. Chang SC, Thibodeaux JR, Eastvold ML et al (2008) Thyroid hormone status and pituitary function in adult rats given oral doses of perfluorooctanesulfonate (PFOS). Toxicology 243:330–339
43. Chang SC, Ehresman DJ, Bjork JA, Wallace KB, Parker GA, Stump DG, Butenhoff JL (2009) Gestational and lactational exposure to potassium perfluorooctanesulfonate (K + PFOS) in rats: toxicokinetics, thyroid hormone status, and related gene expression. Reprod Toxicol 27:387–399
44. Yu WG, Liu W, Jin YH, Liu XH, Wang FQ, Liu L, Nakayama SF (2009) Prenatal and postnatal impact of perfluorooctane sulfonate (PFOS) on rat development: a cross-foster study on chemical burden and thyroid hormone system. Environ Sci Technol 43:8416–8422
45. Gutshall DM, Pilcher GD, Langley AE (1989) Mechanism of the serum thyroid hormone lowering effect of perfluoro-n-decanoic acid (PFDA) in rats. J Toxicol Environ Health 28:53–65
46. Weiss JM, Andersson PL, Lamoree MH, Leonards PE, van Leeuwen SP, Hamers T (2009) Competitive binding of poly- and perfluorinated compounds to the thyroid hormone transport protein transthyretin. Toxicol Sci 109:206–216
47. Yu WG, Liu W, Jin YH (2009) Effects of perfluorooctane sulfonate on rat thyroid hormone biosynthesis and metabolism. Environ Toxicol Chem 28:990–996
48. Curran I, Hierlihy SL, Liston V (2008) Altered fatty acid homeostasis and related toxicologic sequelae in rats exposed to dietary potassium perfluorooctanesulfonate (PFOS). J Toxicol Environ Health 71:1526–1541
49. Yu WG, Liu W, Liu L, Jin YH (2011) Perfluorooctane sulfonate increased hepatic expression of OAPT2 and MRP2 in rats. Arch Toxicol 85:613–621
50. Wieneke N, Neuschäfer-Rube F, Bode LM, Kuna M, Andres J, Carnevali LC Jr, Hirsch-Ernst KI, Püschel GP (2009) Synergistic acceleration of thyroid hormone degradation by phenobarbitol and the peroxisome proliferation receptor agonist WY14643. Toxicol Appl Pharmacol 240:99–107
51. Lau C, Thibodeaux JR, Hanson RG, Rogers JM, Grey BE, Stanton ME, Butenhoff JL (2003) Stevenson LA (2003), Exposure to perfluorooctane sulfonate during pregnancy in rat and mouse. II: postnatal evaluation. Toxicol Sci 74:382–392
52. Luebker DJ, York RG, Hansen KJ, Moore JA, Butenhoff JL (2005) Neonatal mortality from in utero exposure to perfluorooctanesulfonate (PFOS) in Sprague–Dawley rats: dose-response, and biochemical and pharamacokinetic parameters. Toxicology 215:149–169
53. Gutshall DM, Pilcher GD, Langley AE (1988) Effect of thyroxine supplementation on the response to perfluoro-n-decanoic acid (PFDA) in rats. J Toxicol Environ Health 24:491–498
54. Langley AE, Pilcher GD (1985) Thyroid, bradycardic and hypothermic effects of perfluoro-n-decanoic acid in rats. J Toxicol Environ Health 15:485–491
55. Butenhoff J, Costa G, Elcombe C, Farrar D, Hansen K, Iwai H, Jung R, Kennedy G Jr, Lieder P, Olsen G, Thomford P (2002) Toxicity of ammonium perfluorooctanoate in male cynomolgus monkeys after oral dosing for 6 months. Toxicol Sci 69:244–257
56. Seacat AM, Thomford PJ, Hansen KJ, Olsen GW, Case MT, Butenhoff JL (2002) Subchronic toxicity studies on perfluorooctanesulfonate potassium salt in cynomolgus monkeys. Toxicol Sci 68:249–264
57. Olsen GW, Burris JM, Burlew MM, Mandel JH (2003) Epidemiologic assessment of worker serum perfluorooctanesulfonate (PFOS) and perfluorooctanoate (PFOA) concentrations and medical surveillance examinations. J Occup Environ Med 45:260–270
58. Olsen GW, Zobel LR (2007) Assessment of lipid, hepatic, and thyroid parameters with serum perfluorooctanoate (PFOA) concentrations in fluorochemical production workers. Int Arch Occup Environ Health 81:231–246
59. Emmett EA, Zhang H, Shofer FS, Freeman D, Rodway NV, Desai C, Shaw LMJ (2006) Community exposure to perfluorooctanoate: relationships between serum levels and certain health parameters. Occup Environ Med 48:771–779
60. Winquist A, Steenland K (2014) Perfluorooctanoic acid exposure and thyroid disease in community and worker cohorts. Epidemiology 25:255–264
61. Shrestha S, Bloom MS, Yucel R (2014) Perfluoroalkyl substances and thyroid function in older adults. Environ Int 75:206–214
62. Dallaire R, Dewailly E, Pereg D, Dery S, Ayotte P (2009) Thyroid function and plasma concentrations of polyhalogenated compounds in Inuit adults. Environ Health Perspect 117:1380–1386
63. Knox SS, Jackson T, Frisbee SJ, Javins B, Ducatman AM (2011) Perfluorocarbon exposure, gender and thyroid function in the C8 health project. J Toxicol Sci 36:403–410
64. Melzer D, Rice N, Depledge MH, Henley WE, Galloway TS (2010) Association between serum perfluorooctanoic acid (PFOA) and thyroid disease in the U.S. National Health and Nutrition Examination Survey. Environ Health Perspect 118:686–692
65. Wen LL, Lin LY, Su TC, Chen PC, Lin CY (2013) Association between serum perfluorinated chemicals and thyroid function in U.S. adults: the National Health and Nutrition Examination Survey 2007–2010. J Clin Endocrinol Metab 98:E1456–E1464
66. Ji K, Kim S, Kho Y, Paek D, Sakong J, Ha J, Kim S, Choi K (2012) Serum concentrations of major perfluorinated compounds among the general population in Korea: dietary sources and potential impact on thyroid hormones. Environ Int 45:78–85
67. Bloom MS, Kannan K, Spliethoff HM, Tao L, Aldous KM, Vena JE (2010) Exploratory assessment of perfluorinated compounds and human thyroid function. Physiol Behav 99:240–245
68. Lopez-Espinosa MJ, Mondal D, Armstrong B, Bloom MS, Fletcher T (2012) Thyroid function and perfluoroalkyl acids in children living near a chemical plant. Environ Health Perspect 120:1036–1041. doi:10.1289/ehp.1104370
69. Pirali B, Negri S, Chytiris S (2009) Perfluorooctane sulfonate and perfluorooctanoic acid in surgical thyroid specimens of patients with thyroid diseases. Thyroid 19:1407–1412. doi:10.1089/thy.2009.0174
70. Shrestha S, Bloom MS, Yucel R, Seegal RF, Wu Q, Kannan K, Rej R, Fitzgerald EF (2015) Perfluoroalkyl substances and thyroid function in older adults. Environ Int 75:206–214
71. Morreale de Escobar G, Obregon MJ, Ruiz de Oña C, Escobar del Rey F (1988) Transfer of thyroxine from the mother to the rat fetus near term: effects on brain 3,5,3′-triiodothyronine deficiency. Endocrinology 122:1521–1531
72. Morreale de Escobar G, Obregon MJ, Escobar del Rey F (2004) Role of thyroid hormone during early brain development. Eur J Endocrinol 151(Suppl 3):U25–U37
73. Wang F, Liu W, Jin Y (2011) Interaction of PFOS and BDE-47 co-exposure on thyroid hormone levels and TH-related gene and protein expression in developing rat brains. Toxicol Sci 121:279–291
74. Thibodeaux JR, Hanson RG, Rogers JM, Grey BE, Barbee BD, Richards JH, Butenhoff JL, Stevenson LA, Lau C (2003) Exposure to perfluorooctane sulfonate during pregnancy in rat and mouse. I: maternal and prenatal evaluations. Toxicol Sci 74:369–381
75. Kim S, Choi K, Ji K (2011) Trans-placental transfer of thirteen perfluorinated compounds and relations with fetal thyroid hormones. Environ Sci Technol 45:7465–7472
76. Fei C, McLaughlin JK, Tarone RE, Olsen J (2007) Perfluorinated chemicals and fetal growth: a study within the Danish National Birth Cohort. Environ Health Perspect 115:1677–1682
77. Chan E, Burstyn I, Cherry N, Bamforth F, Martin JW (2011) Perfluorinated acids and hypothyroxinemia in pregnant women. Environ Res 111:559–564
78. Wang Y, Starling AP, Haug LS, Eggesbo M, Becher G, Thomsen C, Travlos G, King D, Hoppin JA, Rogan WJ, Longnecker MP (2013) Association between perfluoroalkyl substances and thyroid stimulating hormone among pregnant women: a cross-sectional study. Environ Health 12:76
79. Berg V, Nøst TH, Hansen S (2015) Assessing the relationship between perfluoroalkyl substances, thyroid hormones and binding proteins in pregnant women; a longitudinal mixed effects approach. Environ Int 77:63–69
80. Wang Y, Rogan WJ, Chen PC, Lien GW, Chen HY, Tseng YC, Longnecker MP, Wang SL (2014) Association between maternal serum perfluoroalkyl substances during pregnancy and maternal and cord thyroid hormones: Taiwan maternal and infant cohort study. Environ Health Perspect 122:529–534
81. Webster GM, Venners SA, Mattman A, Martin JW (2014) Associations between perfluoroalkyl acids (PFASs) and maternal thyroid hormones in early pregnancy: a population-based cohort study. Environ Res 133:338–347
82. Yang L, Li J, Lai J (2016) Placental transfer of perfluoroalkyl substances and associations with thyroid hormones: Beijing prenatal exposure study. Sci Rep 6:21699
83. Apelberg BJ, Goldman LR, Calafat AM, Herbstman JB, Kuklenyik Z, Heidler J, Needham LL, Halden RU, Witter FR (2007) Determinants of fetal exposure to polyfluoroalkyl compounds in Baltimore, Maryland. Environ Sci Technol 41:3891–3897
84. Liu J, Li J, Liu Y, Chan HM, Zhao Y, Cai Z, Wu Y (2011) Comparison on gestation and lactation exposure of perfluorinated compounds for newborns. Environ Int 37:1206–1212
85. Inoue K, Okada F, Ito R (2004) Perfluorooctane sulfonate (PFOS) and related perfluorinated compounds in human maternal and cord blood samples: assessment of PFOS exposure in a susceptible population during pregnancy. Environ Health Perspect 112:1204–1207
86. Kato K, Wong LY, Jia LT, Kuklenyik Z, Calafat AM (2011) Trends in exposure to polyfluoroalkyl chemicals in the U.S. population: 1999–2008. Environ Sci Technol 45:8037–8045
87. de Cock M, de Boer MR, Lamoree M, Legler J, van de Bor M (2014) Prenatal exposure to endocrine disrupting chemicals in relation to thyroid hormone levels in infants—a Dutch prospective cohort study. Environ Health 13:106